J Trauma
-
Critically ill trauma patients undergo many radiologic studies, but the cumulative radiation dose is unknown. The purpose of this study was to estimate the cumulative effective dose (CED) of radiation resulting from radiologic studies in critically ill trauma patients. ⋯ From a radiobiologic perspective, risk-to-benefit ratios of radiologic studies are favorable, given the importance of medical information obtained. Current practice patterns regarding use of radiologic studies appear to be acceptable.
-
Nonoperative management of radiographically defined solid organ injuries has proven highly successful in children with blunt splenic and hepatic injuries. The role of nonoperative management protocols is less well defined for blunt renal injuries. The purpose of this study was to review the management and outcome of a consecutive series of children with blunt renal injury. ⋯ A nonoperative management strategy was advantageous and successful in pediatric blunt renal injuries (94.7% successful nonoperative rate, 98.9% renal salvage rate). Adjunctive urologic procedures (e.g., ureteral stenting) were beneficial in selected cases.
-
Hextend (HEX) is a colloid solution that is FDA-approved for volume expansion during surgery. ATL-146e is a novel adenosine A2A receptor agonist that has anti-inflammatory, neuroprotective, and coronary vasodilator properties. Three series of experiments were designed to evaluate the therapeutic potential of HEX+/-ATL-146e for emergency resuscitation from traumatic brain injury (TBI) + hemorrhagic hypotension. ⋯ HEX alone is a safe and efficacious low volume alternative to initial crystalloid resuscitation after TBI. An adenosine A2A agonist combined with 1 L of HEX safely and effectively counteracted a decrease in cardiac performance noted after TBI+hemorrhage without causing hypotension or bradycardia.
-
The Injury Severity Score (ISS) is widely used for anatomic severity assessments. The ISS is the sum of the squares of a patient's three worst Abbreviated Injury Scale (AIS) severities (1-6) from three specified body regions. The set of three AIS severities (including 0s) is called a "triplet." ISS values of 9, 17, 18, 25, 26, 27, 29, 33, 34, 41, and 50 can originate from two unique triplets, but it is not clear whether the mortalities of the triplets are equal. A related question regards the monotonicity of the ISS, that is, whether mortality increases with successive values of ISS. This study sought to compare the mortality of equivalent ISS values from different triplets and to evaluate whether ISS is a monotonic function of mortality. ⋯ The ISS is a nonmonotonic, triplet-dependent function of mortality. Those who persist in using the ISS to describe populations or make risk adjustments should do so cautiously, being sure to account for triplet type. These suspect ISS values appear in approximately 25% of cases.
-
Uncontrolled hemorrhage is a leading cause of death in cases of trauma. Many products currently are under development to control traumatic bleeding. One such Food and Drug Administration (FDA)-approved product is QuikClot. This study determined the efficacy of QuikClot, a hemostatic agent, in reducing blood loss and mortality in a standardized model of severe liver injury as well as the consequences of its use. ⋯ QuikClot provides hemostasis and decreased mortality in this model of severe liver injury. The beneficial aspects of QuikClot treatment must, however, be balanced against the tissue-damaging effects of the exothermic reaction.